Literature DB >> 23273920

Loss of p53 in enterocytes generates an inflammatory microenvironment enabling invasion and lymph node metastasis of carcinogen-induced colorectal tumors.

Sarah Schwitalla1, Paul K Ziegler, David Horst, Valentin Becker, Irina Kerle, Yvonne Begus-Nahrmann, André Lechel, K Lenhard Rudolph, Rupert Langer, Julia Slotta-Huspenina, Franz G Bader, Olivia Prazeres da Costa, Markus F Neurath, Alexander Meining, Thomas Kirchner, Florian R Greten.   

Abstract

Loss of p53 is considered to allow progression of colorectal tumors from the adenoma to the carcinoma stage. Using mice with an intestinal epithelial cell (IEC)-specific p53 deletion, we demonstrate that loss of p53 alone is insufficient to initiate intestinal tumorigenesis but markedly enhances carcinogen-induced tumor incidence and leads to invasive cancer and lymph node metastasis. Whereas p53 controls DNA damage and IEC survival during the initiation stage, loss of p53 during tumor progression is associated with increased intestinal permeability, causing formation of an NF-κB-dependent inflammatory microenvironment and the induction of epithelial-mesenchymal transition. Thus, we propose a p53-controlled tumor-suppressive function that is independent of its well-established role in cell-cycle regulation, apoptosis, and senescence.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23273920     DOI: 10.1016/j.ccr.2012.11.014

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  131 in total

Review 1.  Emerging cytokine networks in colorectal cancer.

Authors:  Nathan R West; Sarah McCuaig; Fanny Franchini; Fiona Powrie
Journal:  Nat Rev Immunol       Date:  2015-09-11       Impact factor: 53.106

Review 2.  Mammalian models of chemically induced primary malignancies exploitable for imaging-based preclinical theragnostic research.

Authors:  Yewei Liu; Ting Yin; Yuanbo Feng; Marlein Miranda Cona; Gang Huang; Jianjun Liu; Shaoli Song; Yansheng Jiang; Qian Xia; Johannes V Swinnen; Guy Bormans; Uwe Himmelreich; Raymond Oyen; Yicheng Ni
Journal:  Quant Imaging Med Surg       Date:  2015-10

Review 3.  Differentiation and Inflammation: 'Best Enemies' in Gastrointestinal Carcinogenesis.

Authors:  Nathan M Krah; L Charles Murtaugh
Journal:  Trends Cancer       Date:  2016-12

4.  Gallid Herpesvirus 1 Initiates Apoptosis in Uninfected Cells through Paracrine Repression of p53.

Authors:  Hai Li; Qi Gao; Yuhao Shao; Bangyao Sun; Fengjie Wang; Yangyang Qiao; Nana Wang; Shengwang Liu
Journal:  J Virol       Date:  2018-08-29       Impact factor: 5.103

Review 5.  Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells.

Authors:  Ugo Testa; Elvira Pelosi; Germana Castelli
Journal:  Med Sci (Basel)       Date:  2018-04-13

6.  Genetic dissimilarity between primary colorectal carcinomas and their lymph node metastases: ploidy, p53, bcl-2, and c-myc expression--a pilot study.

Authors:  Khaled Refaat Zalata; Mohamed Farouk Elshal; Abd AlRahman Mohammad Foda; Ashraf Shoma
Journal:  Tumour Biol       Date:  2015-04-04

Review 7.  Tumor cell plasticity: the challenge to catch a moving target.

Authors:  Sarah Schwitalla
Journal:  J Gastroenterol       Date:  2014-02-25       Impact factor: 7.527

8.  Lineage Plasticity in Cancer Progression and Treatment.

Authors:  Clémentine Le Magnen; Michael M Shen; Cory Abate-Shen
Journal:  Annu Rev Cancer Biol       Date:  2017-12-01

Review 9.  The gastrointestinal tumor microenvironment.

Authors:  Michael Quante; Julia Varga; Timothy C Wang; Florian R Greten
Journal:  Gastroenterology       Date:  2013-04-10       Impact factor: 22.682

10.  Inflammation-induced JMJD2D promotes colitis recovery and colon tumorigenesis by activating Hedgehog signaling.

Authors:  Minghui Zhuo; Wenbo Chen; Shaohui Shang; Peng Guo; Kesong Peng; Ming Li; Pingli Mo; Yongyou Zhang; Xingfeng Qiu; Wengang Li; Chundong Yu
Journal:  Oncogene       Date:  2020-02-24       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.